Valuation: LENSAR, Inc.

Market Cap 74.58M 66.6M 61.52M 55.75M 104M 7.08B 106M 740M 293M 3.71B 280M 274M 11.69B P/E 2026 *
7.14x
P/E 2027 * -27x
Enterprise Value 74.58M 66.6M 61.52M 55.75M 104M 7.08B 106M 740M 293M 3.71B 280M 274M 11.69B EV / Sales 2026 *
1.22x
EV / Sales 2027 * 1.02x
Free-Float
78.48%
Yield 2026 *
-
Yield 2027 * -
1 day+0.83%
1 week+4.66%
Current month-7.89%
1 month-14.20%
3 months+8.39%
6 months+19.25%
Current year-47.81%
1 week 5.68
Extreme 5.68
6.1
1 month 5.68
Extreme 5.68
6.97
Current year 4.95
Extreme 4.95
12.94
1 year 4.95
Extreme 4.95
12.94
3 years 1.8
Extreme 1.8
17.31
5 years 1.8
Extreme 1.8
17.31
10 years 1.8
Extreme 1.8
17.31
Manager TitleAgeSince
Chief Executive Officer 70 2012-01-31
Director of Finance/CFO 52 2026-05-28
Chief Operating Officer 55 2007-12-31
Director TitleAgeSince
Director/Board Member 70 2012-01-31
Chairman 80 2017-11-07
Director/Board Member 78 2018-02-01
Date Insider Type Main position Quantity % Market Cap. Importance
6/3/26 Free

Controller/Auditor

13,066 0.1079%
6/3/26
North Run Capital LP
OtherCompany 0 0% -
6/3/26 Free

Chief Executive Officer

130,662 1.0795%
Change 5-day change 1-year change 3-year change Capi.($)
+0.83%+4.66%-49.29%+178.44% 74.58M
-0.40%-2.34%+17.70%+47.04% 249B
+0.33%+0.64%+3.36%+17.10% 162B
+1.90%+6.00%-17.24%+63.05% 157B
-0.70%+2.93%-54.81%-10.34% 66.22B
+0.15%+4.09%+10.25%+63.82% 52.3B
+0.24%+0.99%-15.49%-12.11% 52.18B
-1.13%+2.85%+17.04%+26.36% 51.34B
-0.47%+0.06%+16.92%+63.83% 48.79B
-0.42%+3.83%+26.19%+82.07% 44.57B
Average +0.03%+2.50%-4.54%+51.93% 88.36B
Weighted average by Cap. +0.14%+1.50%+1.37%+39.09%

Financials

2026 *2027 *
Net sales 61.3M 54.74M 50.57M 45.83M 85.74M 5.82B 87.16M 609M 241M 3.05B 230M 225M 9.61B 72.77M 64.98M 60.03M 54.4M 102M 6.91B 103M 722M 286M 3.62B 273M 267M 11.41B
Net income 37.7M 33.67M 31.1M 28.18M 52.73M 3.58B 53.6M 374M 148M 1.88B 141M 138M 5.91B -2.83M -2.53M -2.34M -2.12M -3.96M -269M -4.03M -28.13M -11.14M -141M -10.63M -10.41M -444M
Net Debt - -
Projected Income Statement - Annual - LENSAR, Inc.
Logo LENSAR, Inc.
LENSAR, Inc. is a commercial-stage medical device company focused on designing, developing, and marketing advanced systems for the treatment of cataracts and the management of astigmatism as an integral aspect of the procedure. The Company's product portfolio includes the LENSAR Laser System and the ALLY Robotic Cataract Laser System and their associated consumable components. It has developed its ALLY System as a compact, highly ergonomic system utilizing an extremely fast dual-modality laser and integrating artificial intelligence into proprietary imaging and software. ALLY is designed to transform cataract surgery by utilizing its advanced robotic technologies with the ability to perform the entire procedure in a sterile operating room or in-office surgical suite. ALLY allows the surgeon to switch between cataract laser and the surgeon’s existing phacoemulsification device without moving patients from room-to-room. ALLY includes its proprietary Streamline software technology.
Employees
150
Date Price Change Volume
26-10-23 US$6.070 +0.83% 28,418
26-10-22 US$6.020 +5.80% 163,211
26-10-21 US$5.690 -2.07% 29,444
26-10-20 US$5.810 +1.04% 51,949
26-10-19 US$5.750 -0.86% 60,342
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
MarketScreener Ratings - LENSAR, Inc.
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
6.070USD
Average target price
11.33USD
Spread / Average Target
+86.71%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - LENSAR, Inc.
  1. Stock Market
  2. Stocks
  3. LNSR Stock